Related Experiment Videos
[Molecular factors determine primary and secondary therapy of breast carcinoma]
U Eppenberger1, W Kueng, S Eppenberger-Castori
1Stiftung Tumorbank Basel, Universitäts-Frauenklinik.
Abstract:
The clinical oncology realizes that the classical approach with systemic adjuvant chemo- and hormonal therapies is not sufficient and will be challenged by cellular and molecular structures which reflect the targets for new therapeutic approaches. These targets are key proteins involved in the signal transduction cascade. In human tumors these proteins have either lost their biological functionality by oncogenic mutations or are constitutively activated. The molecular classification of primary breast cancer was performed by assessing the following factors: estrogen- and progesterone receptors, ERbB-2 mutated p53, uPA, PAI-I, VEGF, DNA-Index and S-Phase. These factors are of prognostic and predictive value.
Insights
Classical cancer treatments are insufficient, necessitating new molecular targets. Molecular classification of breast cancer using key proteins and biomarkers offers prognostic and predictive value for improved therapies.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Context:
- Classical chemo- and hormonal therapies show limitations in clinical oncology.
- Emerging cellular and molecular structures offer novel therapeutic targets.
- Key proteins in signal transduction cascades are often dysregulated in human tumors.
Purpose:
- To explore molecular targets for new therapeutic approaches in cancer treatment.
- To perform molecular classification of primary breast cancer.
- To assess the prognostic and predictive value of specific molecular factors.
Summary:
- Molecular classification of primary breast cancer involves assessing estrogen and progesterone receptors, ERbB-2, mutated p53, uPA, PAI-I, VEGF, DNA-Index, and S-Phase.
- These molecular factors are crucial for understanding tumor biology and guiding treatment decisions.
- Dysregulated proteins in signal transduction cascades represent key targets for novel oncological interventions.
Impact:
- Identified molecular factors provide prognostic and predictive value for breast cancer patients.
- This molecular approach challenges the sufficiency of traditional therapies.
- Advances in understanding molecular targets pave the way for personalized cancer medicine.